HOW DO FOXGLOVE PLANTS MAKE HEART MEDICINE?
In the first paper, released in the Journal of Chromatography A, the scientists explain techniques for assessing the exact mass and framework of heart glycosides, and contrasts substances found in Digitalis purpurea and Digitalis lanata.
mampukah ac milan scudetto musim ini
In the second study, released in the journal Information in Short, they expand on the first, providing additional information on qualities of heart glycosides in both species.
"When we looked at the heart glycosides in each of them, we found extreme distinctions," Wang says. "In the commercial strain that is grown for medication, you see a lot greater quantities of heart glycosides, with a lot more variety. I think this simply highlights the adjustment of plants and how flexible they are as chemists."
"WE CAN STUDY ALL OF THE AVAILABLE COMPOUNDS THAT ARE FOUND IN THE PLANTS AND THEN COME UP WITH OUR OWN DESIGN OF COMPOUNDS THAT ARE SAFER AND MORE EFFECTIVE."
Digitalis lanata is cultivated for medication because it makes a heart glycoside called digoxin. This substance is harmful in large amounts, but it is recommended moderately, in small dosages, to treat heart failing and certain heart rhythm abnormalities.
Present techniques for creating digoxin are troublesome: Because each foxglove grow makes just a bit of the chemical, farmers must expand the plant in huge amounts, Wang says. That consumes a great deal of agricultural land. The delay time is also lengthy.
"It takes 2 years, from the moment you grow the seed to the moment the fallen leaves prepare to gather, and after that you need to dry it in the silo," Wang says. "After that, the grow is crushed right into powder, and the substance is drawn out and cleansed using chemical processes."
If Wang's group can determine, detailed, how foxgloves make heart glycosides, researchers could take advantage of that information to explore a variety of improvements.
Biologists could designer fast-growing microorganisms, such as yeast or safe stress of germs, to produce heart glycosides faster. Grow researchers could genetically designer foxgloves to earn bigger quantities of digoxin, which would certainly increase the effectiveness of ranches and maximize land for various other useful crops.
Medical chemists could also work to develop new medications that resemble digoxin but safer.
"We can gain from nature," Wang says. "We can study all the available substances that are found in the plants and after that come up with our own design of substances that are safer and more effective. That is why I think it is important to not simply concentrate on the present medication digoxin, but to expand our focus to all the substances in the same course, the heart glycosides."
Resource: College at Buffalo
